Health researchers have cited immediate postpartum family planning as one of the high-impact interventions to address unwanted pregnancies in the country, calling for the scaling up of investment.
We spoke with Dr. Kayode Afolabi of the Nigerian Federal Ministry of Health and Dr. Anthony Nwala of PSI local partner Society for Family Health about why now is the time for hormonal IUD scale up.
Category Country Program Operations
Region Washington, DC
Scope of Work
Overview
PSI seeks a fulltime, fixed term
Project Management Consultant to provide overall coordination and project management support for two different research-focused projects: the Consumer s Market for Family Planning (CM4FP) study and Research for Scalable Solutions (R4S) project.
CM4FP is focused on three strategic BMGF countries - Kenya, Nigeria and Uganda - this project is testing a new methodology for measuring contraceptive availability and market dynamics and their localized impact on family planning (FP) uptake. The study has produced data and now we are moving into the delivery phase of the project, focused on analysis and dissemination of results, with a project end date of July 2020.
Posted February 11, 2021
“Everything is about sex… except sex.
Sex is about power,” – Oscar Wilde
The above quote has stuck with me in the week since UNFPA’s Executive Director Dr. Natalia Kanem used it – a quote from poet Oscar Wilde – to open the International Conference on Family Planning’s
If, as Wilde says, sex is about power, then:
… how can we deepen our understanding of the contextual forces that shape how consumers perceive their SRH?
… what more can we do to better support consumers to use their voice, choice and agency to make their health and life choices?
… how might we better address power divides to deliver gender transformative programming?
Posted December 15, 2020 Impact Area Menstrual Health
By Madeleine Moore, Consultant & Technical Advisor, PSI-Europe, Judith Elena Brauer, Program Manager & SRHR Technical Adviser, PSI-Europe and Odette Hekster, Managing Director, PSI-Europe
Menstruation is a normal and natural part of the reproductive system, and over half of the world’s population experiences menstruation throughout their lifetime. Women and girls’ experience with menstruation is an important determinant and outcome of sexual and reproductive health and rights (SRHR). Growing evidence exists about the associations between menstrual health and fertility, contraceptive use, reproductive tract infections, maternal health and HIV and AIDS. Despite this, menstrual health and hygiene (MHH) remains a neglected component of SRHR that affects the life course of many women and girls worldwide.